Inhibitory effect of terpene nerolidol on the growth of Babesia parasites

Parasitology International

Volumn 59, Issue 2, 2010, Pages 278-282

  AbouLaila, Mahmoud ^a,b   Sivakumar, Thillaiampalam ^a,c   Yokoyama, Naoaki ^a   Igarashi, Ikuo ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b MENOUFIA UNIVERSITY   (Egypt)

^c Veterinary Research Institute   (Sri Lanka)

Author keywords

Babesia; In vitro; In vivo; Nerolidol

Indexed keywords

NEROLIDOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABESIA BIGEMINA; BABESIA BOVIS; BABESIA CABALLI; BABESIA OVATA; BABESIOSIS; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; GROWTH INHIBITION; IC 50; IN VITRO STUDY; MOUSE; NONHUMAN; PARASITE VIABILITY; PRIORITY JOURNAL;

ANIMALS; BABESIA; BABESIA BOVIS; BABESIA MICROTI; BABESIOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; MACROPHAGES; MICE; PARASITIC SENSITIVITY TESTS; SESQUITERPENES; TREATMENT OUTCOME;

BABESIA; BABESIA BIGEMINA; BABESIA BOVIS; BABESIA CABALLI; BABESIA MICROTI; BABESIA OVATA; PLASMODIUM FALCIPARUM;

EID: 77951653115     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2010.02.006     Document Type: Article

References (31)

1. Homer M.J., Aguilar-Delfin I., Telford III S.R., Krause P.J., and Persing D.H. Babesiosis. Clin Microbiol Rev 13 (2000) 451-469
2. Kuttler K.L. Worldwide impact of babesiosis. In: Ristic M. (Ed). Babesiosis of domestic animals and man (1988), CRC Press Inc., Boca Raton 1-22
3. Bork S., Yokoyama N., and Igarashi I. Recent advances in the chemotherapy of babesiosis by Asian scientist: toxoplasmosis and babesiosis in Asia. Asian Parasitol 4 (2005) 233-242
4. Vial H.J., and Gorenflot A. Chemotherapy against babesiosis. Vet Parasitol 138 (2006) 147-160
5. Gleeson M.T. The plastid in Apicomplexa: what use is it?. Int J Parasitol 30 (2000) 1053-1070
6. Wilson R.J., and Williamson D.H. Extrachromosomal DNA in the Apicomplexa. Microbiol Mol Biol Rev 61 (1997) 1-16
7. Fichera M.E., and Roos D.S. A plastid organelle as a drug target in apicomplexan parasites. Nature 390 (1997) 407-409
8. Vaishnava S., and Striepen B. The cell biology of secondary endosymbiosis-how parasites build, divide, and segregate the apicoplast. Mol Microbiol 61 (2006) 1380-1387
9. Jomaa H., Wiesner J., Sanderbrand S., Altincicek B., Weidemeyer C., Hintz M., et al. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285 (1999) 1573-1576
10. Goad L.J., Holz Jr. G.G., and Beach D.H. Sterols of Leishmania species: implications for biosynthesis. Mol Biochem Parasitol 10 (1984) 161-170
11. Ellis J.E., Setchell K.D., and Kaneshiro E.S. Detection of ubiquinone in parasitic and free-living protozoa, including species devoid of mitochondria. Mol Biochem Parasitol 65 (1994) 213-224
12. Yokoyama K., Trobridge P., Bruckner F.S., Scholten J., Stuart K.D., Voorhis W.C.V., et al. The effects of protein farnesyltransferase inhibitors on trypanosomatids: inhibition of protein farnesylation and cell growth. Mol Biochem Parasitol 94 (1998) 87-97
13. Brayton K., Lau A., Herndon D., Hannick L., Kappmeyer L., Berens S., et al. Genome sequence of Babesia bovis and comparative analysis of apicomplexan hemoprotozoa. PLoS Pathog 3 (2007) 1401-1413
14. Arruda D., D'Alexandri F., Katzin A., and Uliana S. Antileishmanial activity of the terpene Nerolidol. Antimicrob Agents Chemother 49 (2005) 1679-1687
15. Rodrigues Goulart H., Kimura E., Peres V., Couto A., Aquino Duarte F., and Katzin A. Terpenes arrest parasite development and inhibit biosynthesis of isoprenoids in Plasmodium falciparum. Antimicrob Agents Chemother 48 (2004) 2502-2509
16. Lopes N., Kato M., Andrade E., Maia J., Yoshida M., Planchart A., et al. Antimalarial use of volatile oil from leaves of Virola surinamensis (Rol.) Warb. by Waiapi Amazon Indians. J Ethnopharmacol 67 (1999) 313-319
17. Avarzed A., Igarashi I., Kanemaru T., Hirumi K., Omata Y., Saito A., et al. Improved in vitro cultivation of Babesia caballi. J Vet Med Sci 59 (1997) 479-481
18. Igarashi I., Njonge F.K., Kaneko Y., and Nakamura Y. Babesia bigemina: in vitro and in vivo effects of curdlan sulfate on the growth of parasites. Exp Parasitol 90 (1998) 290-293
19. Bork S., Okamura M., Matsuo T., Kumar S., Yokoyama N., and Igarashi I. Host serum modifies the drug susceptibility of Babesia bovis in vitro. Parasitology 130 (2005) 489-492
20. Bork S., Yokoyama N., Ikehara Y., Kumar S., Sugimoto C., and Igarashi I. Growth-inhibitory effect of heparin on Babesia parasites. Antimicrob Agents Chemother 48 (2004) 236-241
21. Bork S., Yokoyama N., Matsuo T., Claveria F.G., Fujisaki K., and Igarashi I. Growth inhibitory effect of triclosan on equine and bovine Babesia parasites. Am J Trop Med Hyg 68 (2003) 34-40
22. Nishisaka M., Yokoyama N., Xuan X., Inoue N., Nagasawa H., Fujisaki K., et al. Characterization of the gene encoding a protective antigen from Babesia microti identified it as the ή subunit of chaperonin-containing T-complex protein 1. Int J Parasitol 31 (2001) 1673-1679
23. Bork S., Yokoyama N., Matsuo T., Claveria F.G., Fujisaki K., and Igarashi I. Clotrimazole, ketoconazole, and clodinafop-propargyl as potent growth inhibitors of equine Babesia parasites during in vitro culture. J Parasitol 89 (2003) 604-606
24. Bork S., Yokoyama N., Matsuo T., Claveria F.G., Fujisaki K., and Igarashi I. Clotrimazole, ketoconazole, and clodinafop-propargyl inhibit the in vitro growth of Babesia bigemina and Babesia bovis (Phylum Apicomplexa). Parasitology 127 (2003) 311-315
25. Bork S., Das S., Okubo K., Yokoyama N., and Igarashi I. Effects of protein kinase inhibitors on the in vitro growth of Babesia bovis. Parasitology 132 (2006) 775-779
26. Nagai A., Yokoyama N., Matsuo T., Bork S., Hirata H., Xuan X., et al. Growth-inhibitory effects of artesunate, pyrimethamine, and pamaquine against Babesia equi and Babesia caballi in in vitro cultures. Antimicrob Agents Chemother 47 (2003) 800-803
27. Nakamura K., Yokoyama N., and Igarashi I. Cyclin-dependent kinase inhibitors block erythrocyte invasion and intraerythrocytic development of Babesia bovis in vitro. Parasitology 135 (2007) 1-7
28. Couto A.S., Kimura E.A., Peres V.J., Uhrig M.L., and Katzin A.M. Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units. Biochem J 341 (1999) 629-637
29. Löw P., Dallner G., Mayor S., Cohen S., Chait B.T., and Menon A.K. The mevalonate pathway in the bloodstream forms of Trypanosoma brucei. J Biol Chem 266 (1991) 19250-19257
30. Parodi A.J., Martin-Barrientos J., and Engel J.C. Glycoprotein assembly in Leishmania mexicana. Biochem Biophys Res Commun 118 (1984) 1-7
31. Kellogg B.A., and Poulter C.D. Chain elongation in the isoprenoid biosynthetic pathway. Curr Opin Chem Biol 1 (1997) 570-578